Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations
The information contained
in this Quarterly Report is intended to update the information contained in our Annual Report on Form 10-K for the year ended December
31, 2024 filed with the Securities And Exchange Commission (the “SEC”) on March 21, 2025, as amended on March 28, 2025 (the
“Form 10-K”) and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” and other information contained in the Form 10-K. The following discussion and
analysis also should be read together with our financial statements and the notes to the financial statements included elsewhere in this
Quarterly Report.
The following discussion
contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Such statements appear in a number of places in this Quarterly Report, including, without limitation, “Management’s
Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance
and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements
speak only as of the date of this Quarterly Report. You should not put undue reliance on any forward-looking statements. We strongly encourage
investors to carefully read the risk factors described in the Form 10-K in the section entitled “Risk Factors” for a description
of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility
to update the forward-looking statements contained in this Quarterly Report. The following should also be read in conjunction with the
unaudited financial statements and notes thereto that appear elsewhere in this Quarterly Report.
Except as otherwise indicated
herein or as the context otherwise requires, references in this Quarterly Report to “we,” “us,” “our,”
“Company,” and “Agrify” refer to Agrify Corporation, a Nevada corporation and its consolidated subsidiaries.
Overview
Agrify is a developer of branded
innovative solutions for the cannabis and hemp industries. Our Señorita brand offers consumers hemp-derived tetrahydrocannabinol
(“THC”) beverages that mirror well-known cocktails like a margarita – in three flavors – classic Lime Jalapeño
Margarita, Mango Margarita, and Paloma. Known for its clean, fresh taste and commitment to high-quality, natural ingredients, Señorita
offers a low-sugar, low-calorie alternative to alcoholic beverages and is available at top retailers including Total Wine, ABC Fine Wine
& Spirits, and Binny’s in ten U.S. states and Canada, with plans for expansion and future availability in premier on-premises
destinations.
In addition to beverages,
Agrify has also historically been a leading provider of innovative cultivation and extraction solutions for the cannabis industry. Prior
to the extraction business disposal on March 30, 2025, our comprehensive extraction product line, which includes hydrocarbon, alcohol,
solventless, post-processing, and lab equipment, empowered producers to maximize the quantity and quality of extract required for premium
concentrates. Additionally, prior to its sale on December 31, 2024, our proprietary micro-environment-controlled Agrify VFUs enabled cultivators
to produce high quality products for the cannabis industry (the “Cultivation Business”).
The Company was formed in
the State of Nevada on June 6, 2016 as Agrinamics, Inc.. On September 16, 2019, Agrinamics amended its articles of incorporation to reflect
a name change to Agrify Corporation.
Reverse Stock Split
On July 5, 2023, we effected
a 1-for-20 reverse stock split of our Common Stock. On October 8, 2024, we effected a 1-for-15 reverse stock split of our Common Stock.
All share and per share information has been retroactively adjusted to give effect to the reverse stock splits for all periods presented
unless otherwise indicated.
Recent Developments
On March 19, 2025, our Board
of Directors appointed Brad Asher to serve as our Chief Financial Officer and our principal financial and accounting officer effective
March 24, 2025. Mr. Asher serves as our Chief Financial Officer pursuant to a Shared Services Agreement with Vision Management Services,
LLC, a subsidiary of Green Thumb, and he will not receive any direct compensation from us.
26
Lines of Business
Hemp-Derived Beverages
The Company acquired the
Señorita brand of hemp-derived THC beverages in November 2024. Señorita was designed and formulated by world-class winemakers
Charles Bieler and Joel Gott. Recognizing a growing generational demand for adult beverage alternatives, Bieler and Gott gave the classic
margarita a modern twist—replacing alcohol with hemp-derived to create a delightful adult beverage alternative. Through the use
of all-natural, premium ingredients like organic Mexican agave, fresh lime juice and sweet, tangy mango, Señorita quickly gained
acclaim, taking home the top spot in The High Times Cannabis Cup just one year after inception. Gott and Bieler continue to collaborate
on the brand with Mr. Kovler and the Agrify team.
Señorita currently offers
three award-winning flavors – classic Lime Jalapeño Margarita, Paloma, and Mango Margarita. A fourth flavor, low-calorie
Ranch Water, is expected to debut in 2025. Señorita’s hemp-derived beverages are currently available at top retailers including
Total Wine, ABC Fine Wine & Spirits, and Binny’s in ten U.S. states and Canada. Products are also available for direct-to-consumer
purchase where permissible under state law at senoritadrinks.com.
Discontinued Operations
Cultivation Solutions
Prior to its sale on December 31, 2024, we sold
proprietary cultivation solutions to independent licensed cultivators. The two primary products we sold were the VFUs and Agrify Insights™
software.
The proprietary VFU technology offered a modular,
compartmentalized micro-climate growing system for indoor vertical farming. The VFU system was designed for craft farmers, single-state
operators, and multi-state operators who were looking to consistently produce higher-quality crops at scale. The VFUs were designed to
line up horizontally in rows, and could be stacked vertically up to three units tall.
The VFUs were designed to
work in conjunction with the Agrify Insights™ software. Each VFU sold included a license for Agrify Insights™ and a monthly
Software-as-a-Service (“SaaS”) subscription fee was charged per VFU. The VFU could not operate successfully without Agrify
Insights™. Agrify Insights™ license agreements were generally for a multi-year term, with an annual auto-renewal.
Extraction Solutions
Prior to its discontinuation on March 30, 2025,
our extraction equipment and business solutions can be used within indoor processing facilities by fully licensed cannabis and hemp cultivators
and processors or in some cases, by individual processors for individual use in compliance with applicable law. We sell our proprietary
extraction solutions to independent, licensed cultivators and processing labs.
We had strategically acquired
four of the top brands in the extraction space in late 2021 and early 2022 in Precision Extraction, PurePressure, Lab Society, and Cascade
Sciences. These brands encompassed hydrocarbon, alcohol, and solventless extraction and distillation and post-processing solutions. Our
extraction brands provided equipment and solutions for extraction, post-processing, and testing for the cannabis and hemp industries.
Use of Estimates
The preparation of financial
statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ
from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense,
valuation allowance for deferred tax assets, goodwill, impairment of long-lived assets, provision for litigation, inventory reserve, fair
value measurements and useful life of fixed assets and intangible assets.
27
Financial Overview
Critical Accounting Policies and Significant
Judgments and Estimates
Our management’s discussion
and analysis of our financial position and results of operations is based on our financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United States of America, or U.S. GAAP. The preparation of financial statements in
conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the financial statements and
accompanying notes. On an ongoing basis, we evaluate estimates, which include estimates related to accruals, and stock-based compensation
expense. We base our estimates on historical experience and other market-specific or other relevant assumptions that we believe to be
reasonable under the circumstances. Actual results may differ materially from those estimates or assumptions.
Warrants
We account for warrants as
either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable
authoritative guidance in Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity
(“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). Management’s assessment considers
whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant
to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants
are indexed to the our own Common Stock among other conditions for equity classification.
For issued or modified warrants
that meet all of the criteria for equity classification, they are recorded as a component of additional paid-in capital at the time of
issuance. For issued or modified warrants that are precluded from equity classification, they are recorded as a liability at their initial
fair value on the date of issuance and marked-to-market each reporting period with the changes in fair value of warrant liabilities recorded
in other income (expense), net in the accompanying unaudited condensed consolidated statements of operations until the warrants are exercised.
The fair value of the warrant liabilities are estimated using a Black-Scholes option-pricing model.
The estimated fair value
of the warrant liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes option-pricing model are assumptions used in
calculating the estimated fair values that represent our best estimate. The volatility rate is determined utilizing our own share price
and the share price of competitors over time.
Revenue Recognition
Overview
The Company generates revenue
from continuing operations through the sale of hemp-derived beverages. In accordance with ASC Topic 606, Revenue Recognition (“ASC
606”), revenue is recognized through a five-step model, as outlined below:
● Identify the customer contract : A customer contract
is identified when there is mutual approval and commitment between the Company and its customer, the rights and obligations are clear,
payment terms are set, the contract has commercial substance, and collectability is probable. Written or electronic signatures on contracts
and purchase orders are obtained if such orders are issued in the normal course of business by the customer.
● Identify performance obligations that are distinct :
The Company identifies distinct performance obligations in each contract. A performance obligation is considered distinct if the customer
can benefit from the good or service on its own or with readily available resources, and if it is separately identifiable from other
promises in the contract. The Company’s revenue-generating activities typically have a single performance obligation.
28
● Determine the transaction price : The transaction price is the amount of consideration the Company
expects to receive in exchange for the sale of the product. This amount is determined excluding sales taxes collected on behalf of government
agencies and net of any sales discounts, incentives, and returns.
● Allocate the transaction price to distinct performance obligations : The transaction price is allocated
to each distinct performance obligation based on the relative SSP of the goods or services provided. If a contract involves multiple performance
obligations, each is accounted for separately if distinct, and the SSP reflects the price the Company would charge if the good or service
were sold separately in similar circumstances and to similar customers.
● Recognize revenue as the performance obligations are satisfied : Revenue is recognized when control
of the product transfers to the customer, typically upon delivery or shipment, as the customer assumes the risks and rewards of ownership.
Payment terms vary by customer, but the time between revenue recognition and payment due is generally not significant. For products sold
under consignment arrangements, revenue is recognized only when control is transferred to the end customer. The Company does not
maintain a specific reserve for returns due to the limited circumstances under which returns are permitted in customer agreements. Payments
for slotting, listing fees, or other marketing or promotional activities, where legally permitted, are recorded as a reduction in revenue
unless a distinct good or service is received in exchange.
Income Taxes
We account for income taxes
pursuant to the provisions of ASC Topic 740, Income Taxes , (“ASC 740”) which requires, among other things, an asset
and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax
assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases
of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is
more likely than not that the net deferred asset will not be realized.
We follow the provisions
of ASC 740-10-25-5, “Basic Recognition Threshold.” When tax returns are filed, it is highly certain that some positions taken
would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position
taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10-25-6, the benefit
of a tax position is recognized in the unaudited condensed consolidated financial statements in the period during which, based on all
available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the
resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions
that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent
likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions
taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying
balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. We believe
our tax positions are all highly certain of being upheld upon examination. As such, we have not recorded a liability for unrecognized
tax benefits.
We recognize the benefit
of a tax position when it is effectively settled. ASC 740-10-25-10, “Basic Recognition Threshold” provides guidance on how
an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits.
ASC 740-10-25-10 clarifies that a tax position can be effectively settled upon the completion of an examination by a taxing authority.
For tax positions considered effectively settled, we recognize the full amount of the tax benefit.
29
Accounting for Stock-Based Compensation
We follow the provisions
of ASC Topic 718, Compensation — Stock Compensation ,(“ASC 718”) establishes standards surrounding the accounting
for transactions in which an entity exchanges its equity instruments for goods or services. ASC Topic 718 focuses primarily on accounting
for transactions in which an entity obtains employee services in share-based payment transactions, such as options issued under our equity
incentive plan.
The fair value of each option
is estimated on the date of grant using the Black-Scholes option-pricing model. This model incorporates certain assumptions for inputs
including a risk-free market interest rate, expected dividend yield of the underlying Common Stock, expected option life, and expected
volatility in the market value of the underlying Common Stock.
The Black-Scholes option-pricing
model was developed for use in estimating the fair value of traded options, which have no vesting restrictions and are fully transferable.
In addition, option valuation models require the input of highly subjective assumptions including the expected stock price volatility.
Because our stock options and warrants have characteristics different from those of our traded stock, and because changes in the subjective
input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily
provide a reliable single measure of the fair value of such stock options. The risk-free interest rate is based upon quoted market yields
for United States Treasury debt securities with a term similar to the expected term. The expected dividend yield is based upon our history
of having never issued a dividend and management’s current expectation of future action surrounding dividends. We calculate the
expected volatility of the stock price based on the corresponding volatility of our peer group stock price for a period consistent with
the underlying instrument’s expected term. The expected lives for such grants were based on the simplified method for employees
and directors.
As permitted under ASC 718,
the Company has made an accounting policy choice to account for forfeitures when they occur.
It is important that the
discussion of our operating results that follows be read in conjunction with the critical accounting policies disclosed above.
30
Results of Operations
Comparison of the Three Months Ended March
31, 2025 and 2024
The following table summarizes
our results of continuing operations for the three months ended March 31, 2025 and 2024:
Three months ended
March 31,
2025
2024
Revenue
$ 538
$ —
Cost of goods sold
448
—
Gross profit
90
—
Selling, general and administrative
3,791
1,552
Research and development
—
275
Change in contingent consideration
—
(2,180 )
Total operating expenses
3,791
(353 )
Operating (loss) income from continuing
operations
(3,701 )
353
Interest income (expense), net
1
(100 )
Change in fair value of warrant liabilities
407
873
Other income, net
19
—
Total other income, net
427
773
(Loss) income from continuing operations before income taxes
(3,274 )
1,126
Income tax provision
—
—
(Loss) income from continuing operations, net of income taxes
(3,274 )
1,126
(Loss) income from discontinued operations
(1,918 )
3,110
Gain on disposal of Extraction business
3,566
—
Income tax effect on discontinued operations
—
—
Income from discontinued operations, net of income taxes
1,648
3,110
Net (loss) income
(1,626 )
4,236
Income (loss) attributable to non-controlling interest
—
—
Net (loss) income attributable to Agrify Corporation
$ (1,626 )
$ 4,236
Net (loss) income per share attributable to Common Stockholders – basic (1)
$ (0.83 )
$ 9.21
Net (loss) income per share attributable to Common Stockholders – diluted (1)
$ (0.83 )
$ 3.78
Weighted average common shares outstanding - basic (1)
1,952,022
460,133
Weighted average common shares outstanding - diluted (1)
1,952,022
1,197,891
Revenues
We generate revenue from
sales of hemp-derived beverages.
Revenues, all of which related
to hemp-derived beverages, increased by $538 thousand, for the three months ended March 31, 2025, as compared to the same period in 2024.
The comparative increase in revenue was primarily driven by the acquisition of Señorita in December 2024 by all revenue from the
Cultivation Business and Extraction Business for the three months ended March 31, 2024 being presented as part of discontinued operations .
31
Cost of Goods Sold
Cost of goods sold represents
costs associated with the hemp-derived beverage sales.
The following table provides
a breakdown of our cost of goods sold from continuing operations for the three months ended March 31, 2025 and 2024:
Three months ended
March 31,
(In thousands)
2025
2024
Change
% Change
Hemp-derived beverages
$ 448
$ —
$ 448
N/A
Total cost of goods sold
$ 448
$ —
$ 448
N/A
Cost of goods sold increased
by $448 thousand for the three months ended March 31, 2025 compared to the same period in 2024. The comparative increase in cost of goods
sold is associated with acquisition of Señorita in December 2024, which aligns with the increase in revenue.
Gross Profit
Three months ended
March 31,
(In thousands)
2025
2024
Change
% Change
Gross profit
$ 90
$ —
$ 90
N/A
Gross profit totaled $90
thousand, or 16.7% of total revenue during the three months ended March 31, 2025.
Selling, General and Administrative
Three months ended
March 31,
(In thousands)
2025
2024
Change
% Change
Selling, general and administrative
$ 3,791
$ 1,552
$ 2,239
144 %
Selling, general and administrative
(“SG&A”) expenses consist principally of salaries and related costs for personnel, including stock-based compensation
and travel expenses, associated with executive and other administrative functions. Other SG&A expenses include, but are not limited
to, professional fees for legal, consulting, depreciation and amortization and accounting services, as well as facility-related costs.
SG&A expense increased by
$2.2 million, or 144%, for the three months ended March 31, 2025, compared to the same period in 2024. The comparative change is primarily
attributable to the acquisition of Señorita in December 2024 driving an increase in consulting and outsourced services of $0.9
million, $0.3 million increase of intangible asset amortization expense and $0.3 million increase in marketing expense.
Research and Development
Three months ended
March 31,
(In thousands)
2025
2024
Change
% Change
Research and development
$ —
$ 275
$ (275 )
(100 )%
Research and development
expense decreased by $275 thousand, or 100% for the three months ended March 31, 2025, compared to the same period in 2024. The decrease
is attributable to the reduction in personnel resulting from the discontinuation of Extraction Business.
32
Other Income, Net
Three months ended
March 31,
(In thousands)
2025
2024
Change
% Change
Interest income (expense), net
$ 1
$ (100 )
$ 101
(101 )%
Change in fair value of warrant liabilities
407
873
(466 )
(53 )%
Other income, net
19
—
19
N/A
Total other income, net
$ 427
$ 773
$ (346 )
(45 )%
Interest income, net was
$1 thousand for the three months ended March 31, 2025, compared to interest expense, net of $100 thousand for the three months ended March
31, 2024. The change is attributable mainly to the decrease in principal balance on outstanding loans as well as the increase in interest
income from higher cash on hand.
The change in fair value
of warrant liabilities decreased by $466 thousand, or 53% during the three months ended March 31, 2025, compared to the same period in
2024. The decrease is primarily related to the fair value remeasurement of warrants.
Other income, net was $19
thousand for the three months ended March 31, 2025, compared to none for the same period in 2024.
Income Tax (Expense) Benefit
There was no income tax
expense or benefit for the three months ended March 31, 2025 and March 31, 2024.
Liquidity and Capital Resources
As of March 31, 2025, our
principal sources of liquidity were cash and cash equivalents and marketable securities totaling $24.4 million. Our current working capital
needs are to support revenue growth and manage inventory to meet demand forecasts and support operational growth. Our long-term financial
needs primarily include working capital requirements. There are many factors that may negatively impact our available sources of funds
in the future, including the ability to generate cash from operations, raise debt capital and raise cash from the issuance of our securities.
The amount of cash generated from operations is dependent upon factors such as the successful execution of our business strategy and
general economic conditions.
As part of our growth strategies,
we may opportunistically raise debt capital and raise cash from the issuance of our securities, subject to market and other conditions.
If additional financing is required from outside sources, we may not be able to raise such capital on terms acceptable to us or at all.
If we are unable to raise additional capital when desired, our business, operating results and financial condition may be adversely affected.
Indebtedness
Green Thumb Convertible Note
On November 5, 2024, we issued
the Secured Convertible Note (“Green Thumb Note”) to the RSLGH, LLC, a subsidiary of Green Thumb. The Green Thumb Note is
a secured obligation and ranks senior to all of our indebtedness. The Green Thumb Note will mature on November 5, 2025 and has a 10.0%
annualized interest rate. The principal amount of the Green Thumb Note will be payable on its maturity date. The Green Thumb Note provides
for advances of up to $20.0 million in the aggregate, of which $10.0 million was advanced upon issuance. If the Investor elects to convert
the Green Thumb Note, the conversion price per share will be $3.158, subject to customary adjustments for certain corporate events. The
conversion of the Green Thumb Note will be subject to certain customary conditions and the receipt of stockholder approval to the extent
necessary under Nasdaq listing rules. The Green Thumb Note was amended on May 8, 2025 to issue pre-funded warrants in lieu of cash interest
with 18,614 pre-funded warrants issued on May 8, 2025 and an additional 11,373 pre-funded warrants to be issued on September 1, 2025,
replacing the previously defined cash interest payment dates. The number of pre-funded warrants is equal to the cash interest amount
otherwise payable on The Green Thumb Note divided by the closing share price on May 8, 2025, which is the effective date of the amendment.
No changes were made to the conversion price of the principal amount of the Green Thumb Note.
33
Cash Flows
The following table presents
the major components of net cash flows from and used in operating, investing, and financing activities for the three months ended March
31, 2025 and 2024:
Three months ended
March 31,
(In thousands)
2025
2024
Net cash (used in) provided by:
Operating activities
$ (6,720 )
$ (2,987 )
Investing activities
—
328
Financing activities
(1 )
2,324
Net decrease in cash and cash equivalents
$ (6,721 )
$ (335 )
Cash Flow from Operating Activities
For the three months ended March 31, 2025, our operating cash flows
included a net loss of $1.6 million, which included $336 thousand related to depreciation and amortization, $589 thousand of stock-based
compensation expense, $407 thousand gain related to the change in fair value of warrant liabilities, and $3.6 million gain on disposal
of Extraction business. Net cash was decreased by changes in operating assets and liabilities of $2.3 million.
For the three months ended
March 31, 2024, we incurred net income of $4.2 million, which included $406 thousand related to depreciation and amortization, $490 thousand
of stock-based compensation expense, and $873 thousand gain related to the change in fair value of warrant liabilities. Net cash was reduced
by changes in operating assets and liabilities of $970 thousand.
Cash Flow from Investing Activities
For the three months ended
March 31, 2025, there were no cash flows from investing activities.
For the three months ended
March 31, 2024, net cash provided in investing activities was $328 thousand, which primarily resulted from $330 thousand in proceeds
from the repayment of a loan receivable.
Cash Flow from Financing Activities
For the three months ended
March 31, 2025, net cash provided by financing activities was immaterial $1 thousand in repayments of notes payable.
For the three months ended
March 31, 2024, net cash provided by financing activities was $2.3 million, primarily driven by proceeds from the issuance of common
stock and warrants of $2.1 million.
Off-Balance Sheet Arrangements
During the periods presented,
we did not have, nor do we currently have, any relationships with unconsolidated entities or financial partnerships, such as entities
often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating
off-balance sheet arrangements or other contractually narrow or limited purposes. We are therefore not exposed to the financing, liquidity,
market, or credit risk that could arise if we had engaged in those types of relationships.
Critical Accounting Policies and Estimates
Part I, Item, 2, “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” discusses our unaudited condensed consolidated financial
statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure
of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results may differ from these estimates under different assumptions or conditions.
These estimates are based
on our knowledge and understanding of current conditions and actions that we may take in the future. Changes in these estimates will
occur as a result of the passage of time and the occurrence of future events. Subsequent changes in these estimates may have a significant
impact on our financial condition and results of operations and are recorded in the period in which they become known. We have identified
the following estimates that, in our opinion, are subjective in nature, require the exercise of judgment and involve complex analysis:
the fair value of derivative assets and liabilities, goodwill impairment assessment, revenue recognition and cost of goods sold.
34
The significant accounting
policies and estimates that have been adopted and followed in the preparation of our condensed consolidated financial statements are detailed
in Note 1 - Overview, Basis of Presentation and Significant Accounting Policies included in the Form 10-K and Note 1 - Overview, Basis
of Presentation and Significant Accounting Policies to our unaudited condensed consolidated financial statements in Part I, Item 1 of
this Quarterly Report. There have been no changes in these policies and estimates that had a significant impact on the financial condition
and results of operations for the periods covered in this Quarterly Report.
Recently Issued Accounting Pronouncements
Adopted
For more information on recently
issued accounting pronouncements are included within Note 1 - Overview, Basis of Presentation and Significant Accounting Policies, included
elsewhere in the notes to unaudited condensed consolidated financial statements covered under Part I, Item 1 of this Quarterly Report.
New Accounting Pronouncements Not Yet Adopted
For more information on new
accounting pronouncements not yet adopted are included within Note 1 - Overview, Basis of Presentation and Significant Accounting Policies,
included elsewhere in the notes to unaudited condensed consolidated financial statements covered under Part I, Item 1 in this Quarterly
Report.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
As a “smaller reporting
company” as defined by 17 C.F.R. § 229.10, the Company is not required to provide information required by this Item.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.